Sunday, November 29, 2020

COVID-19 vaccine | SII rejects claims of Covishield#39;s adverse effect, threatens to seek damages in excess of Rs 100 crore

COVID-19 vaccine | SII rejects claims of Covishield#39;s adverse effect, threatens to seek damages in excess of Rs 100 crore The volunteer is falsely laying the blame for his medical problems on the trial of COVID-19 vaccine Covishield, said Serum Institute of India

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-vaccine-|-sii-rejects-claimscovishield39s-adverse-effect-threatens-to-seek-damagesexcessrs-100-crore_14538241.html
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

S&P 500, Nasdaq end higher on Amazon-OpenAI deal; Fed path forward grows murky

Artificial intelligence deals propelled the S&P 500 and Nasdaq higher on Monday, with Amazon's $38 billion agreement with OpenAI and...